Pharmacogenomics and Pediatric Asthmatic Medications
Asthma is a respiratory condition often stemming from childhood, characterized by difficulty breathing and/or chest tightness. Current treatment options for both adults and children include beta-2 agonists, inhaled corticosteroids (ICS), and leukotriene modifiers (LTM). Despite recommendations by th...
Main Authors: | Christy Lim, Ronny Priefer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Journal of Respiration |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-527X/2/1/3 |
Similar Items
-
Inhaled corticosteroids and leukotriene modifiers as mono-therapy for mild persistent asthma
by: Amr Radwan, et al.
Published: (2013-07-01) -
Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01) -
Improvement of Asthma Management in Actual Practice Consistent with Prevalence of Anti-inflammatory Agents—Based on Questionnaire Surveys in Niigata Prefecture, Japan from 1998 to 2002—
by: Takashi Hasegawa, et al.
Published: (2005-01-01) -
Additive effect of cysteinyl leukotriene or thromboxane modifiers to inhaled corticosteroids in asthmatic patients
by: Shigeharu Myou, et al.
Published: (2004-01-01) -
Addition of Leukotriene Receptor Antagonists to Inhaled Corticosteroids Improved QOL of Patients with Bronchial Asthma Surveyed in Suburban Tokyo, Japan
by: Nobuharu Ohshima, et al.
Published: (2011-01-01)